Patents show all

29Issued20Applications

SEC Filings show all

D3S-11

SEC Form D Funding Events

DateOfferedSoldType
2012-01-13$17,125,000$16,759,991Equity
2009-06-12$9,438,712$9,438,712Equity, Option to Acquire
2006-04-18UnknownUnknownOther (Paper Filing)

Key Executives

  • Mary Fisher
    Executive Officer, Director
  • David F. Hale
    Director
  • Graham D.s. Anderson
    Director
  • Rex Bright
    Director
  • James H. Cavanaugh, Ph.D.
    Director
  • Brian H. Dovey
    Director
  • Richard E. Fitzpatrick, M.D.
    Director
  • Adele C. Oliva
    Director
  • William A. Roper, Jr.
    Director
  • Andrew N. Schiff, M.D.
    Director
  • Christina Balesteri
    Executive Officer
  • Theodore Ebel
    Executive Officer
  • Thomas H. Insley
    Executive Officer
  • Theodore Schwarz
    Executive Officer
  • Rob Sorensen
    Executive Officer
  • George Jenkins
    Director
  • Steve P. Loomis
    Executive Officer